Loading, please wait...
Date: May 24, 2023 07:00 PM - 08:00 PM
Location: UIW Feik School of Pharmacy, 703 E. Hildebrand, San Antonio, TX, 78212
CE Hours
1.00
CE Units
0.100
Registration closes on Jul 07, 2023 11:55 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
|
The University of the Incarnate Word Feik School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Joint Provider(s)
Bexar County Pharmacy Association (BCPA) and Central Texas Society of Health-System Pharmacists (CTSHP)
Requirements for CE Credit
- The participant will only receive credit for programs after receiving a 70% on a post-test and an evaluation form is completed and submitted.
- The entire session must be attended to receive credit. No partial credit will be given.
- Certificates will not be mailed. Contact hours will be uploaded to NABP's CPE Monitor after successful completion of post-test and program evaluation.
- To receive credit, participant profiles must contain a valid NABP e-profile ID number and month/date of birth.
- All requirements to receive credit must be completed within six weeks of participation in the CPE program. Failure to complete requirements within the six-week window will result in no credit awarded to the participant.
|
Please choose a Fee Type from the Drop Down Menu Below:
I am a
|
Registration closes on Jul 07, 2023
at 11:55 PM
Registration closes on Jul 07, 2023
at 11:55 PM
Registration Closed
Registration Closed
Upon the completion of this activity, pharmacist will be able to:
1. List pharmacologic options recommended for treatment of heart failure and describe limitations associated
with their use.
2. Identify key changes in heart failure treatment between the 2022 AHA/ACC/HFSA Clinical Practice Guideline
and previously published guideline recommendations.
3. Summarize primary literature guiding updated treatment recommendations for heart failure.
with their use.
2. Identify key changes in heart failure treatment between the 2022 AHA/ACC/HFSA Clinical Practice Guideline
and previously published guideline recommendations.
3. Summarize primary literature guiding updated treatment recommendations for heart failure.
Speaker(s)/Author(s)
|
Lauren Lozano |
Activity Number
0445-9999-23-012-L01-P
Date:
05/24/23
Time:
07:00 PM - 07:45 PM
CE Hours
1.00
Location
FSOP 513
Registration Closed